Evidence map›Paper›PMID 31373203›Full record

ArticleACS infectious diseases2019

Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit

Yvett Sosa, Roman Deniskin, I J Frame, Matthew S Steiginga, Deepak Bandyopadhyay, Todd L Graybill, Lorena A Kallal, Michael T Ouellette, Andrew J Pope, Katherine L Widdowson and 2 more

Open access · greenAbstract read
In one paragraph

Article in ACS infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. TargetingFrontiers in microbiology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yvett Sosa
Roman Deniskin
I J Frame
Matthew S SteigingaPlatform Technology & Science and Discovery Partners in Academia , GlaxoSmithKline , 1250 South Collegeville Road , Collegeville , Pennsylvania 19426 , United States.
Deepak BandyopadhyayPlatform Technology & Science and Discovery Partners in Academia , GlaxoSmithKline , 1250 South Collegeville Road , Collegeville , Pennsylvania 19426 , United States.
Todd L GraybillPlatform Technology & Science and Discovery Partners in Academia , GlaxoSmithKline , 1250 South Collegeville Road , Collegeville , Pennsylvania 19426 , United States.
Lorena A KallalPlatform Technology & Science and Discovery Partners in Academia , GlaxoSmithKline , 1250 South Collegeville Road , Collegeville , Pennsylvania 19426 , United States.
Michael T OuellettePlatform Technology & Science and Discovery Partners in Academia , GlaxoSmithKline , 1250 South Collegeville Road , Collegeville , Pennsylvania 19426 , United States.
Andrew J PopePlatform Technology & Science and Discovery Partners in Academia , GlaxoSmithKline , 1250 South Collegeville Road , Collegeville , Pennsylvania 19426 , United States.
Katherine L WiddowsonPlatform Technology & Science and Discovery Partners in Academia , GlaxoSmithKline , 1250 South Collegeville Road , Collegeville , Pennsylvania 19426 , United States.
Robert J YoungPlatform Technology & Science and Discovery Partners in Academia , GlaxoSmithKline , 1250 South Collegeville Road , Collegeville , Pennsylvania 19426 , United States.ORCID 0000-0002-7763-0575
South College · USAlbert Einstein College of Medicine · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007288 · NIGMS · YESHIVA UNIVERSITY · PI AKABAS, MYLES H. · 1985 to 2022
$35.6M
Geographic Medicine and Emerging InfectionsT32AI070117 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI WEISS, LOUIS M. · 2008 to 2023
$5.1M
Inhibitors of Purine Import into Plasmodium falciparum Kill Malaria ParasitesR01AI116665 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI AKABAS, MYLES H. · 2015 to 2019
$3.5M
Characterizing and targeting malaria parasite purine uptake pathways to generate novel antimalarial drugsF31AI136488 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SOSA, YVETT D · 2018 to 2020
$123k
NIAID NIH HHS F31 AI136488NIAID NIH HHS R01 AI116665NIAID NIH HHS T32 AI070117NIGMS NIH HHS T32 GM007288
6 · The paper itself

Abstract

Emerging resistance to current antimalarial medicines underscores the importance of identifying new drug targets and novel compounds. Malaria parasites are purine auxotrophic and import purines via the

Indexed as

Drug DiscoveryAntimalarialsBiological TransportCell ProliferationErythrocytesGene Knockout TechniquesHep G2 CellsHigh-Throughput Screening AssaysHumansMalariaMalaria, FalciparumNucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport ProteinsPlasmodium falciparumProtozoan ProteinsPurinesTranscriptomeAntimalarialsENT1 protein, Plasmodium falciparumNucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport ProteinsProtozoan ProteinspurinePurinesdrug discoveryhigh throughput screenmalariapurinetransporter

Identifiers

PMID31373203
PMCPMC7171677
OpenAlexW2965917592

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.